Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
As a result of an author oversight in the original article [1], the legend of Figure 5A and C is inaccurate and one panel in Figure 5C (FOXM1N H929 cells shown in the top row, left) is wrong.
Main Authors: | Chunyan Gu, Xuefang Jing, Carol Holman, Ramakrishna Sompallae, Fenghuang Zhan, Guido Tricot, Ye Yang, Siegfried Janz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | BMC Cancer |
Online Access: | https://doi.org/10.1186/s12885-019-6443-1 |
Similar Items
-
Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
by: Chunyan Gu, et al.
Published: (2018-11-01) -
NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase
by: Zhimin Gu, et al.
Published: (2017-01-01) -
Germline Risk Contribution to Genomic Instability in Multiple Myeloma
by: Siegfried Janz, et al.
Published: (2019-05-01) -
FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
by: Zhu X, et al.
Published: (2020-10-01) -
Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes
by: Philpott Michael P, et al.
Published: (2010-02-01)